Scinai Immunotherapeutics Ltd (SCNI)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
1,050,200
EV to revenue ratio (TTM)
5.31
EV to ebitda
1.132
Financial Performance
Revenue (TTM)
1,487,000
Gross profit (TTM)
-3,752,000
EBITDA
-6,636,000
Profitability
Operating margin (TTM)
-466.50%
Profit margin
-174.80%
Return on assets (TTM)
-36.10%
Return on equity (TTM)
-26.50%
Per Share Metrics
Revenue per share (TTM)
2.8
EPS
28.07
Diluted EPS (TTM)
28.07
Book value
10.71
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
0.055
Trailing P/E
0.055
Forward P/E
PEG ratio
Price to sales ratio (TTM)
0.706
Price to book ratio (TTM)
0.22
Growth
Quarterly earnings growth (YoY)
146.00%
Quarterly revenue growth (YoY)
87.20%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
2.084